|
NDE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.011600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.303750E-01 |
| Normal-vs-Stage2 |
1.161560E-02 |
| Normal-vs-Stage3 |
1.378800E-01 |
| Normal-vs-Stage4 |
3.984600E-01 |
| Stage1-vs-Stage2 |
7.730000E-02 |
| Stage1-vs-Stage3 |
5.503400E-01 |
| Stage1-vs-Stage4 |
7.838000E-01 |
| Stage2-vs-Stage3 |
3.063400E-01 |
| Stage2-vs-Stage4 |
1.235630E-01 |
| Stage3-vs-Stage4 |
5.542000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.710240E-01 |
| Normal-vs-AfricanAmerican |
9.565800E-01 |
| Normal-vs-Asian |
4.649800E-01 |
| Caucasian-vs-AfricanAmerican |
3.623800E-01 |
| Caucasian-vs-Asian |
6.532400E-01 |
| AfricanAmerican-vs-Asian |
5.806200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.853600E-02 |
| Normal-vs-Female |
1.442790E-01 |
| Male-vs-Female |
2.575200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.297600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.006240E-02 |
| Normal-vs-Age(61-80Yrs) |
8.823600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.662800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.600700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.824000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.759800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.343400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.816800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.751800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.301200E-01 |
| Classical-VS-Follicular |
1.09169999706893E-08 |
| Classical-VS-Other |
1.766830E-01 |
| Classical-VS-Normal |
4.512800E-01 |
| Tall-VS-Follicular |
1.946130E-02 |
| Tall-VS-Other |
3.536800E-01 |
| Tall-VS-Normal |
9.822400E-01 |
| Follicular-VS-Other |
5.884400E-01 |
| Follicular-VS-Normal |
3.83569999999889E-05 |
| Other-VS-Normal |
1.550450E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.620000E-03 |
| Normal-vs-N1 |
5.555800E-02 |
| N0-vs-N1 |
9.103000E-01 |
|
|
